As a clinician, TheraNow's founder constantly filters decisions through his own user mindset, asking if he, as a patient or therapist, would use the product. This practice provides an intuitive check against building features that add complexity rather than solving real-world problems for the end user.

Many firms view patient engagement as a compliance task that adds cost. However, data shows integrating patient experience into development from the start speeds up clinical trial recruitment and execution, reduces FDA amendments, and accelerates time-to-market, providing clear ROI.

For devices treating chronic conditions, the most clinically effective solution is useless if patients don't use it daily. Fitting into a patient's routine, ensuring comfort, and simplifying operation are paramount drivers of adherence and, ultimately, real-world outcomes.

By releasing new software features weekly based on direct feedback from surgeons in the clinic, Andromeda has compressed the typical multi-year MedTech development cycle into weeks. This rapid, customer-centric improvement loop is shocking to the traditionally slow-moving medical industry.

Synchrony Medical discovered a major flaw in their vest not in a lab, but by watching people try to put it on themselves. Observing this unassisted, real-world task revealed the air tubes were a tripping hazard, prompting a crucial redesign that would have been costly to fix later.

In complex ecosystems, you can't prioritize one stakeholder at the expense of another. In healthcare, while the patient's needs are paramount, enabling providers to do their best work is a prerequisite for excellent patient care. Product decisions must treat the patient-provider dynamic as an interconnected system where there can be no loser.

A common failure in biotech is viewing patients solely as data sources rather than as human partners in the development process. This perspective leads to unnecessarily complex protocols with high patient burden. The most successful firms build relationships with patient advocacy groups and design trials that respect the patient's experience.

A crucial piece of advice for biotech founders is to interact with patients as early as possible. This 'patient first' approach helps uncover unmet needs in their treatment journey, providing a more powerful and differentiated perspective than focusing solely on the scientific or commercial landscape.

Shift the AI development process by starting with workshops for the people who will live with the system, not just those who pay for it. The primary goal is to translate their stories and needs into tangible checks for fairness and feedback before focusing on technical metrics like accuracy and speed.